A study from the University of Cambridge published in Science identified the protein Prdx1 as a new therapeutic target for immunotherapy against cancer; by blocking its action, tumor cells can be attacked again by T lymphocytes. (translated)
In the research on the melanoma vaccine, 50 Poles participated, and the results indicate that the new personalized therapy may reduce the risk of death and distant metastases by as much as 60%. (translated)
The article presents the most important breakthroughs in medicine, such as research on stem cells, advances in robotics, innovative immunotherapy, and GLP-1 drugs that have the potential to revolutionize the treatment of many diseases and improve the quality of life for patients. (translated)
Experimental, personalized cancer vaccine called intismeran autogene, based on mRNA technology and used in combination with immunotherapy, slowed the recurrence of melanoma and its spread to other parts of the body. Together on this treatment method. (translated)
Starting from October 1, significant changes will be introduced in Poland for the treatment of lung cancer, including the possibility of reapplying immunotherapy, the introduction of therapeutic breaks, and a national screening program, aimed at better tailoring therapies to the needs of patients and improving their quality of life. (translated)
This could be one of the most important moments in the development of personalized cancer immunotherapy: for the first time, an mRNA-based neoantigen therapy has achieved a positive result in a phase III trial. (translated)
The personalized mRNA vaccine against melanoma, being developed by Moderna and MSD, shows promising results in prolonging disease-free survival time in patients after surgery, and its efficacy combined with immunotherapy is promising, heralding a new era in cancer treatment, with the planned market introduction of the product in 2027. (translated)
A new personalized melanoma vaccine, based on mRNA technology and used in combination with immunotherapy, shows promising results in clinical trials, reducing the risk of disease recurrence or death by 49% over five years, suggesting its potential use in treating patients with advanced-stage cancer. (translated)
An experimental vaccine against melanoma developed by Merck and Moderna showed promising results in its first phase 3 clinical study, leading to a 130% increase in Moderna's shares and a 10.8% increase for Merck. (translated)
A personalized mRNA vaccine against melanoma, used in combination with immunotherapy, shows promising results in a phase III clinical trial, significantly extending disease-free survival time in patients at high risk of melanoma. (translated)
Research on the personalized vaccine intismeran, administered in combination with the immunotherapy Keytruda, showed an extension of the relapse-free period of melanoma and a reduction in the risk of metastasis, which has raised hopes for a new era of oncology therapies and positive reactions on the stock market. (translated)
An experimental vaccine against melanoma developed by Merck and Moderna has shown promising results in its first advanced clinical trial, contributing to a significant increase in the stock prices of both companies. (translated)
Moderna and Merck have announced promising preliminary results from the phase 3 study comparing a personalized mRNA therapy, autogene intismeran, combined with the immunotherapy KEYTRUDA, showing a significant reduction in the risk of recurrence and metastasis in patients operated on for advanced melanoma, which caused Moderna's stock to soar by 96% in pre-market trading. (translated)
Thread on therapeutic anti-tumor vaccines. What are they? They are vaccines that do not prevent the onset of tumors but train the immune system to recognize and destroy cancer cells already present in the body. How do they work and how are they designed? (translated)
Zespół naukowców z Uniwersytetu Kalifornijskiego w Los Angeles odkrył, że kreatyna może wzmocnić efektywność nowoczesnych terapii immunologicznych w walce z rakiem, poprawiając działanie limfocytów T oraz wspierając metabolizm komórek dendrytycznych, co może przyczynić się do lepszej odpowiedzi organizmu na nowotwory. #Kreatyna #Immunoterapia #Nowotwory
Immunotherapy, targeted therapies, CAR-T, conjugated antibodies. All achieved thanks to trials supported by industry in collaboration with academic centers. In summary, behind every new experimental study there is an enormous, costly, and highly complicated effort. (translated)
Le cellule dendritiche, identificati come architette degli avamposti anti-cancro, svolgono un ruolo cruciale nella creazione e nel mantenimento di raggruppamenti di cellule immunitarie che coordinano risposte contro i tumori, offrendo nuove prospettive per migliorare l'efficacia delle immunoterapie. #CelluleDendritiche #Immunoterapia #Cancro
Jan, któremu początkowo wydawało się, że zmaga się z problemami z kręgosłupem, przeszedł dramatyczną diagnozę nowotworu płuc w czwartym stadium po miesiącach bagatelizowania objawów, co skłoniło go do szybkiej i intensywnej ścieżki diagnostycznej i terapeutycznej. #rak #diagnostyka #immunoterapia
Un nuovo studio condotto da ricercatori della Weill Cornell Medicine ha rivelato che nanoparticelle di silice ingegnerizzate possono distruggere le cellule tumorali della prostata attivando un processo di autodistruzione chiamato ferroptosi e migliorando la risposta immunitaria, aprendo la strada a potenziali nuovi trattamenti per il cancro prostatico. #tumoreprostata #nanoparticelle #immunoterapia
Nanoparticelle ingegnerizzate a base di silice si sono dimostrate estremamente efficaci nel combattere il tumore alla prostata, inducendo le cellule tumorali all'autodistruzione e attivando il sistema immunitario, portando a casi di remissione completa in studi su topi. #Nanoparticelle #TumoreAllaProstata #Immunoterapia
